Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostacyclin I2 (PGI2) increases left ventricular ejection fraction (LVEF).

C Auinger1, I Virgolini, M Weissel

  • 1Dept. of Nuclear Medicine, University of Vienna, Austria.

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|June 1, 1989
PubMed
Summary

Prostacyclin (PGI2) infusion improved left ventricular ejection fraction (LVEF) in patients with impaired heart function. This study suggests PGI2 may offer temporary LVEF enhancement for specific clinical needs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.

Nuklearmedizin. Nuclear medicine·2014
Same author

Effect of natural amino alcohols on the yield of essential amino acids and the amino acid pattern in stressed barley.

Amino acids·2013
Same author

Influence of PET reconstruction parameters on the TrueX algorithm. A combined phantom and patient study.

Nuklearmedizin. Nuclear medicine·2013
Same author

Validation for 2D/3D registration. I: A new gold standard data set.

Medical physics·2011
Same author

Efficient implementation of the rank correlation merit function for 2D/3D registration.

Physics in medicine and biology·2010
Same author

Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication.

Surgical endoscopy·2007

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Impaired left ventricular ejection fraction (LVEF) is a critical indicator of cardiac dysfunction.
  • Prostacyclin (PGI2), a potent vasodilator, has potential therapeutic applications in cardiovascular conditions.

Purpose of the Study:

  • To evaluate the acute effects of intravenous Prostacyclin (PGI2) infusion on left ventricular ejection fraction (LVEF) in patients with pre-existing LVEF impairment.

Main Methods:

  • Ten patients with impaired LVEF underwent intravenous PGI2 infusion at two dosage rates (1 ng/kg/min and 5 ng/kg/min).
  • Left ventricular ejection fraction (LVEF) was assessed using 99mTc-pertechnetate radionuclide ventriculography before and during PGI2 administration.

Main Results:

  • PGI2 infusion led to a significant increase in LVEF, from a baseline of 34.7% to 36.2% at 1 ng/kg/min and 43.8% at 5 ng/kg/min (p < 0.01).

Related Experiment Videos

  • Individual patient data revealed dose-dependent improvements in LVEF, with some patients showing significant enhancement at the higher PGI2 dose.
  • No correlation was observed between changes in hemodynamic parameters and the PGI2-induced LVEF improvement.

    • Conclusions:

    • Prostacyclin (PGI2) demonstrates beneficial effects on left ventricular ejection fraction (LVEF) in patients with impaired cardiac function.
    • PGI2 may serve as a potential therapeutic agent for temporary LVEF improvement in specific clinical scenarios, such as pre-heart transplantation.